Literature DB >> 11712925

Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.

J M Wright, T L Perry, K L Bassett, G K Chambers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11712925

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

1.  Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

Authors:  Peter Jüni; Anne W S Rutjes; Paul A Dieppe
Journal:  BMJ       Date:  2002-06-01

Review 2.  Selective COX-2 inhibitors: a health economic perspective.

Authors:  David L B Schwappach; Christian M Koeck
Journal:  Wien Med Wochenschr       Date:  2003

3.  Individualizing drug therapy, and 'men behaving badly'.

Authors:  E J Begg
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

4.  Transparency in drug regulation: mirage or oasis?

Authors:  Joel Lexchin; Barbara Mintzes
Journal:  CMAJ       Date:  2004-11-23       Impact factor: 8.262

5.  Ethics and the publication of research.

Authors:  Max Perlman
Journal:  Paediatr Child Health       Date:  2003-04       Impact factor: 2.253

6.  Evolution of evidence-based medicine to detect evidence mutations.

Authors:  Brian S Alper; Zbys Fedorowicz; Sheri A Strite; Michael E Stuart; Allen F Shaughnessy
Journal:  J R Soc Med       Date:  2015-01       Impact factor: 5.344

7.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

Review 8.  The double-edged sword of COX-2 selective NSAIDs.

Authors:  James M Wright
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

Review 9.  COX-2 inhibitors: a CLASS act or Just VIGORously promoted.

Authors:  Samir Malhotra; N Shafiq; P Pandhi
Journal:  MedGenMed       Date:  2004-03-23

10.  Age and rising rates of cyclooxygenase-2 inhibitor use. Results from a national survey.

Authors:  Michael A Steinman; Kenneth R McQuaid; Kenneth E Covinsky
Journal:  J Gen Intern Med       Date:  2006-02-22       Impact factor: 5.128
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.